Polysaccharide Microvesicle Isolation for Clinical Diagnostics

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for isolating microvesicles are not well developed for routine clinical diagnostic and prognostic applications, particularly in cancer and other pathological conditions, limiting their effectiveness in early diagnosis and monitoring.

Innovation Solution

A method involving the use of polysaccharides to isolate microvesicles from biological samples, allowing for the detection of pathological markers and monitoring of condition progression or treatment responsiveness.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional isolation methods are used, then microvesicles can be obtained, but the isolation efficiency and purity are insufficient for routine clinical diagnostic applications

Engineering Contradiction:
Improveisolation efficiencyVSAvoidisolation purity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent uses polysaccharides as intermediary substances that selectively bind to microvesicles through specific molecular interactions. The polysaccharides act as mediators between the complex biological sample and the isolation process, enabling efficient capture and purification of microvesicles while maintaining their integrity and biological activity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs parameter changes in the form of varying polysaccharide concentrations, molecular weights, and structural configurations to optimize microvesicle isolation. By adjusting these parameters, the method achieves both high isolation efficiency and purity, resolving the contradiction between productivity and manufacturing precision.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If current isolation technologies are applied, then microvesicles can be isolated, but the technology is not well developed for routine clinical diagnostic and prognostic application

Engineering Contradiction:
Improveroutine clinical applicabilityVSAvoiddiagnostic reliability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The polysaccharide-based isolation method is designed to be self-service in nature, where the polysaccharides automatically recognize and bind to microvesicles through specific molecular patterns without requiring complex external controls or specialized equipment. This simplifies the operation for routine clinical use while maintaining high reliability through the specificity of the polysaccharide-microvesicle interaction.

Inventive Principle:
Principle #25Self-service

3Measurement precision

If microvesicles are isolated for diagnostic purposes, then early diagnosis capability can be improved, but the isolation method must be both efficient and suitable for clinical settings

Engineering Contradiction:
Improvediagnostic precisionVSAvoidisolation method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts the essential isolation function by using simple polysaccharide substances that can be easily incorporated into clinical workflows. This extraction approach removes the complexity of conventional multi-step isolation procedures while maintaining or enhancing diagnostic precision through selective microvesicle capture.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables efficient isolation and analysis of microvesicles, facilitating early diagnosis, monitoring of pathological conditions, and assessment of treatment responsiveness, improving clinical diagnostic capabilities.

Implementation Method 1

contacting the sample with at least one polysaccharide under conditions for the isolation of the microvesicles

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS10488403B2Method for the isolation of microvesicles
Publication Date: 2019.11.26 ATLANTIC CANCER RES INST
  • US10488403B2 patent drawing
  • US10488403B2 patent drawing
  • US10488403B2 patent drawing

AI summary

The present disclosure relates to a method for the isolation of microvesicles comprising contacting the sample with at least one polysaccharide to isolate the microvesicles.